CHMP recommends bigger doses of Doribax for tough infections
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's scientific committee has recommended that the benefits of J&J's antibacterial Doribax (doripenem) outweigh its risks, and that physicians should be allowed to use higher dose of the antibiotics in some circumstances.